Publications by authors named "Elisabetta Kuhn"

Article Synopsis
  • There are currently no specific biomarkers to identify patients with advanced ovarian carcinoma who are responsive to bevacizumab (BEV), a key treatment option.
  • A study analyzed TP53 mutations and p53 expression in advanced ovarian cancer patients undergoing BEV treatment, finding that unclassified missense TP53 mutations significantly improved overall survival.
  • The results suggest that unclassified TP53 mutations could serve as a favorable prognostic indicator in these patients, indicating the need for further research to explore their potential role in predicting treatment outcomes.
View Article and Find Full Text PDF

Endometrial carcinoma (EC) is the most frequent gynecological cancer, with an increasing incidence and mortality in recent times. The last decade has represented a true revolution with the development of the integrated histo-molecular classification of EC, which allows for the stratification of patients with morphologically indistinguishable disease into groups with different prognoses. Particularly, the POLE-mutated subgroup exhibits outstanding survival.

View Article and Find Full Text PDF
Article Synopsis
  • The rise of precision medicine brings more targeted cancer treatments and advanced techniques for analyzing molecular data, but understanding this data can be complex.
  • Molecular tumor boards, which include various healthcare professionals, help interpret these data and provide valuable insights for doctors while also promoting knowledge sharing and research.
  • The analysis discusses how molecular tumor boards operate, the professionals involved, the types of data used, and highlights successful examples from current multi-institutional, disease-specific initiatives.
View Article and Find Full Text PDF
Article Synopsis
  • Peritoneal metastases from colorectal cancer are tough to treat, and while surgeries combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can help, high recurrence rates and a lack of a standard chemotherapy choice remain challenges.
  • This study explored the use of patient-derived organoids (PDO) as a model to enhance the effectiveness of HIPEC by testing various chemotherapy drugs on PDOs from twelve patients.
  • Results showed significant variability in drug responses, highlighting that certain combinations, like mitomycin-c with cisplatin, were most effective, suggesting that PDOs can help tailor treatments and improve strategies for individual patients with colorectal cancer peritoneal metastases.
View Article and Find Full Text PDF

PTEN hamartoma tumour syndrome (PHTS) comprises different hereditary conditions caused by germline PTEN mutations, predisposing to the development of multiple hamartomas in many body tissues and also increasing the risk of some types of cancer. Cerebellar involvement in PHTS patients has been long known due to the development of a pathognomonic cerebellar hamartoma (known as dysplastic gangliocytoma of the cerebellum or Lhermitte-Duclos disease). Recently, a crucial role of the cerebellum has been highlighted in the pathogenesis of autism spectrum disorders, now recognised as a phenotype expressed in a variable percentage of PHTS children.

View Article and Find Full Text PDF

The neurofibromatosis-1 gene () was initially characterized because its germline mutation is responsible for an inherited syndromic disease predisposing tumor development, in particular neurofibromas but also various malignancies. Recently, large-scale tumor sequencing efforts have demonstrated as one of the most frequently mutated genes in human cancer, being mutated in approximately 5-10% of all tumors, especially in malignant peripheral nerve sheath tumors and different skin tumors. acts as a tumor suppressor gene that encodes neurofibromin, a large protein that controls neoplastic transformation through several molecular mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • Lymphovascular invasion (LVI) is a key pathological feature associated with poor prognosis in cancers like breast carcinoma, and its assessment is now mandated in pathology reports.* -
  • There are challenges in the consistent interpretation of LVI among pathologists, which leads to variability and affects reproducibility in assessments.* -
  • While genomic assays have taken precedence in determining treatment strategies for breast cancer, LVI can still play a significant role in guiding adjuvant therapy in certain cases.*
View Article and Find Full Text PDF

Despite their rarity, thymic epithelial tumors (TETs) have attracted much interest over the years, leading to an impressive number of histological and staging classifications. At present, TETs are divided by the WHO classification into four main subtypes: type A, type AB, and type B thymomas (subdivided into B1, B2, and B3), and thymic carcinomas, going from the more indolent to the most aggressive ones. Among many debated staging proposals, the TNM and the Masaoka-Koga staging systems have been widely accepted and used in routine practice.

View Article and Find Full Text PDF

Purpose: To (1) identify a radiological parameter to predict non-functioning pituitary tumor (NFPT) consistency, (2) examine the relationship between NFPT consistency and extent of resection (EOR), (3) investigate if tumor consistency predictors can anticipate EOR.

Methods: The ratio (T2SIR) between the T2 min signal intensity (SI) of the tumor and the T2 mean SI of the CSF was the main radiological parameter, being determined through a radiomic-voxel analysis and calculated using the following formula: T2SIR = [(T2 tumor mean SI - SD)/T2 CSF SI]. The tumor consistency was pathologically estimated as collagen percentage (CP).

View Article and Find Full Text PDF

Purpose: PTEN hamartoma tumor syndrome (PHTS) comprises a group of rare genetic conditions caused by germline mutations in PTEN gene and characterized by development of both benign and malignant lesions in many body tissues. In this study, we aimed to evaluate the incidence of thyroid findings in both adult and pediatric PHTS patients.

Methods: A retrospectively analysis conducted in 19 (13 adult and 6 pediatric) patients with PHTS, all confirmed with genetic testing, observed from 2015 to 2021 at the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

View Article and Find Full Text PDF

Context.—: Extramedullary hematopoiesis (EMH) is an uncommon occurrence, usually associated with hematologic disorders, but it rarely presents as an isolated finding.

Objective.

View Article and Find Full Text PDF

Introduction: Plasma cell gingivitis (PCG) is a chronic inflammatory disease usually affecting the vestibular portion of the gingival mucosa. Clinical presentation is marked by erythematous macules of intense red color, confluent, and delimited from the healthy neighboring mucosa. Generally asymptomatic, the gum lesions sometimes are accompanied by burning sensations and a sense of local tension.

View Article and Find Full Text PDF

Lynch syndrome (LS) is the most common inherited disorder responsible for an increased risk of developing cancers at different sites, most frequently in the gastrointestinal and genitourinary tracts, caused by a germline pathogenic variant affecting the DNA mismatch repair system. Surveillance and risk-reducing procedures are currently available and warranted for LS patients, depending on underlying germline mutation, and are focused on relevant targets for early cancer diagnosis or primary prevention. Although pharmacological approaches for preventing LS-associated cancer development were started many years ago, to date, aspirin remains the most studied drug intervention and the only one suggested by the main surveillance guidelines, despite the conflicting findings.

View Article and Find Full Text PDF

Basal cell carcinoma (BCC) is the most common form of skin cancer, affecting more often elderly patients, but sometimes even younger ones, particularly if immunocompromised or genetically predisposed. Specifically, the Gorlin-Goltz syndrome, an autosomal dominant genodermatosis, also known as nevoid basal cell carcinoma syndrome, characterizes for multiple early onset BCCs. It is caused by a germline mutation in , a tumor suppressor gene whose product is the key component of Hedgehog (Hh) signaling pathway, which also appears somatically mutated in more than 85% of sporadic BCCs.

View Article and Find Full Text PDF

Odontoma is the most common benign odontogenic tumor of epithelial and mesenchymal origin. The standard treatment involves a conservative approach. While this procedure is generally well accepted and tolerated, some difficulties may arise in case of odontomas associated with cystic lesions.

View Article and Find Full Text PDF

Background: GATA binding protein 3 () expression is positively correlated with estrogen receptor (ER) expression, but its prognostic value as an independent factor remains unclear. Thus, we undertook the current study to evaluate the expression of and its prognostic value in a large series of breast carcinomas (BCs) with long-term follow-up.

Methods: A total of 702 consecutive primary invasive BCs resected between 1989 and 1993 in our institution were arranged in tissue microarrays, immunostained for ER, progesterone receptor (PR), ki-67, HER2, p53, and , and scored.

View Article and Find Full Text PDF

Tumors of the parathyroid glands are highly vascularized and display a microRNA (miRNA) profile divergent from normal parathyroid glands (PaNs). Angiogenic miRNAs, namely miR-126-3p, miR-126-5p, and miR-296-5p, have been found downregulated in parathyroid tumors. Here, we show that miR-126-3p expression levels are reduced in parathyroid adenomas (PAds; n = 12) compared with PaNs (n = 4).

View Article and Find Full Text PDF

Anaplastic carcinoma (AC) is a rare but highly aggressive form of thyroid cancer. It mostly arises on a background of pre-existing well-differentiated cancer (WDC); however, whether it evolves directly from a WDC or originates as a second independent neoplasm is still to be defined. To obtain further insights into these mechanisms, we performed morphological, immunohistochemical, and next-generation sequencing analyses to compare AC and its associated WDC in a subset of 13 surgically resected specimens.

View Article and Find Full Text PDF

Molecular alterations that contribute to long-term (LT) and short-term (ST) survival in ovarian high-grade serous carcinoma (HGSC) may be used as precision medicine biomarkers. DNA promoter methylation is an early event in tumorigenesis, which can be detected in blood and urine, making it a feasible companion biomarker to somatic mutations for early detection and targeted treatment workflows. We compared the methylation profile in 12 HGSC tissue samples to 30 fallopian tube epithelium samples, using the Infinium Human Methylation 450K Array.

View Article and Find Full Text PDF

Angiosarcoma and anaplastic carcinoma are the most lethal neoplasms of the thyroid worldwide and share some similarities, which have led to a longstanding controversy on their etiopathological relationship. Thyroid angiosarcomas are characterized by vessel formation and an immunophenotype common to endothelial cells, while anaplastic carcinomas are partially or wholly composed of mesenchymal-like cells that have lost the morphologic and functional features of normal thyroid follicular cells. To investigate whether angiosarcomas represent the endothelial extreme of the differentiation spectrum of carcinomas or they are bona fide vascular neoplasms, we studied the clinico-morphologic and genetic characteristics of a series of 10 angiosarcomas and 22 anaplastic carcinomas.

View Article and Find Full Text PDF
Article Synopsis
  • Anaplastic thyroid cancer (ATC) is a rare and very aggressive type of thyroid cancer, while differentiated papillary thyroid cancer (DM-PTC) usually is not aggressive.
  • Researchers studied the genetics of ATC, DM-PTC, and non-aggressive thyroid cancer samples using advanced DNA analysis techniques.
  • They found that ATC and DM-PTC have different genetic features, but both types share a specific mutation pattern that seems to be linked to more aggressive cancer behavior.
View Article and Find Full Text PDF

Immunohistochemistry is a valuable adjunct in routine gynaecological pathology. The molecular revolution has redesigned knowledge of gynaecological cancers and refined histological classification. The direct consequence has been the progressive introduction of new immunostainings for diagnostic and classification purposes.

View Article and Find Full Text PDF